Complicated spastic paraplegia in patients with AP5Z1 mutations (SPG48)
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Article Information
- Received February 4, 2016
- Accepted in final form July 6, 2016
- First Published August 25, 2016.
Author Disclosures
- Jennifer Hirst, PhD*,
- Marianna Madeo, PhD*,
- Katrien Smets, MD*,
- James R. Edgar, PhD,
- Ludger Schols, MD, Dr med,
- Jun Li, MD, PhD,
- Anna Yarrow, BA,
- Tine Deconinck, MSci,
- Jonathan Baets, MD, PhD,
- Elisabeth Van Aken, MD, PhD,
- Jan De Bleecker, MD, PhD,
- Manuel B. Datiles III, MD,
- Ricardo H. Roda, MD, PhD,
- Joachim Liepert, MD,
- Stephan Züchner, MD, PhD,
- Caterina Mariotti, MD,
- Peter De Jonghe, MD, PhD,
- Craig Blackstone, MD, PhD and
- Michael C. Kruer, MD
- Jennifer Hirst, PhD*,
NONE
NONE
NONE
BMC Cell Biology, Associate Editor, 2015/2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Wellcome Trust (086598) to Margaret S. Robinson
NONE
NONE
NONE
NONE
NONE
NONE
- Marianna Madeo, PhD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Katrien Smets, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- James R. Edgar, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Wellcome Trust grant number 086598, awarded to Prof. Margaret S. Robinson
NONE
NONE
NONE
NONE
NONE
NONE
- Ludger Schols, MD, Dr med,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
As participant of the MICONOS trial I received fees from Santhera Pharmaceuticals
I received the following grants: PI: Genetic disorders in Arab Societies (grant SCHO754/5-2), DFG: 2014-2016 PI: mitoMORPH (mitoNET, grant 01GM0864), BMBF: 2008-2014 PI: EUROSCAR (01GM1207) EU/BMBF: 2012-2015 PI: NEUROMICS (F5-2012-305121) EU: 2012-2017
NONE
I received additional funding from the HSP-Selbsthilfegruppe Deutschland eV and the F?rderverein fuer HSP-Forschung
NONE
NONE
NONE
NONE
NONE
NONE
- Jun Li, MD, PhD,
Muscular Dystrophy Association (non-profit) Charcot-Marie-Tooth Association (non-profit)
NONE
NONE
Journal of the Peripheral Nervous System, editorial member Experimental Neurology, editorial member Neurology: Neuroimmunology & Neuroinflammation, editorial member Neural Regeneration Research, editorial member
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anna Yarrow, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tine Deconinck, MSci,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan Baets, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elisabeth Van Aken, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jan De Bleecker, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Manuel B. Datiles III, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
US National Institutes of Health in Bethesda, MD, a US Federal government research institution: Medical Officer and Senior/Principal Investigator.
The Johns Hopkins University School of Medicine, Baltimore, MD, USA: Adjunct Associate Professor in Ophthalmology.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ricardo H. Roda, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH intramural research program.
Johns Hopkins University New York University
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joachim Liepert, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stephan Züchner, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Caterina Mariotti, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research support from an FP7 Grant from the European Commission (HEALTH-F2-2010- 242193).European Friedreich Ataxia Consortium for Translational Studies (EFACTS)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Peter De Jonghe, MD, PhD,
NONE
NONE
NONE
(1) Acta Neurologica Belgica; editorial advisory board; 2009-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Fund for Scientific Research, International Coordination Action;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Craig Blackstone, MD, PhD and
NONE
NONE
NONE
(1) Journal of Clinical Investigation, Board of Consulting Editors, 2010-present (2) Journal of Neuromuscular Diseases, Editorial Board, 2014-present (3) Annals of Neurology, Editorial Board, 2015-2018 No compensation received for any of the above.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NINDS Intramural Research Program, National Institutes of Health, NS002992, NS003025, and NS003128, Principal Investigator, 2001-present
NONE
NONE
NONE
(1) Monoclonal antibody against the human atlastin-1 protein, licensed to EMD Millipore Corporation, $1000 in 2016 and $1075 in 2016. Not related to the study.
NONE
NONE
NONE
NONE
- Michael C. Kruer, MD
Advisory committee, Lundbeck (2015)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Speakers? Bureau, Huntington Disease Society of America (2015-)
NONE
NONE
Grant support, Retrophin (2014-)
NIH NINDS NS083739
NONE
Doris Duke Charitable Foundation CSDA2014112
NONE
NONE
NONE
NONE
NONE
Consultant, HRSA National Vaccine Injury & Compensation Program (2015-)
- From the Cambridge Institute for Medical Research (J.H., J.R.E.), University of Cambridge, Addenbrooke's Hospital, UK; Children's Health Research Center (M.M., A.Y.), Cancer Biology Research Center, Sanford Research, Sioux Falls; Neurogenetics Group (K.S., T.D., J.B., P.D.J.), Department of Molecular Genetics VIB, Antwerp, Belgium; Department of Neurology (K.S., J.B., P.D.J.), Antwerp University Hospital, Belgium; Laboratories of Neurogenetics and Neuropathology (K.S., T.D., J.B., P.D.J.), Institute Born-Bunge, University of Antwerp, Belgium; Department of Neurology (L.S., J. Liepert), Hertie Institute for Clinical Brain Research, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE) (L.S.), Tübingen, Germany; Department of Neurology (J. Li), Vanderbilt University, Nashville, TN; Department of Ophthalmology (E.V.A.), Department of Neurology (J.D.B.), Ghent University Hospital, Belgium; National Eye Institute (M.B.D.), National Institutes of Health, Bethesda, MD; Cell Biology Section (R.H.R., C.B.), Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; Department of Neurology (R.H.R.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurorehabilitation (J. Liepert), Kliniken Schmieder, Allensbach, Germany; Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), Miller School of Medicine, University of Miami, FL; Genetics of Neurodegenerative and Metabolic Diseases Unit (C.M.), IRCCS-Fondazione Istituto Neurologico Carlo Besta, Milan, Italy; Departments of Child Health, Neurology & Genetics (M.C.K.), University of Arizona College of Medicine, Phoenix; Program in Neuroscience (M.C.K.), Arizona State University, Tempe; and Pediatric Movement Disorders Program and Neurogenetics Research Program (M.C.K.), Barrow Neurological Institute, Phoenix Children's Hospital, AZ.
- Correspondence to Dr. Kruer: mkruer{at}phoenixchildrens.com
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.